Literature DB >> 32150364

Acute Coronary Syndrome: Presentation and Diagnostic Evaluation.

Craig Barstow1.   

Abstract

Acute coronary syndrome (ACS) is an acute myocardial infarction (MI) or ischemia, usually from acutely disrupted coronary artery blood flow. Patients commonly present to the emergency department (ED) with chest pain or pressure but sometimes have atypical symptoms. Evaluation begins with an electrocardiogram (ECG) obtained within 10 minutes of presentation. If ST-segment elevation is present, ST-segment elevation MI (STEMI) is diagnosed. If STEMI is not present, troponin levels should be measured using one of several recommended protocols. Troponin levels greater than 99th percentile of the upper reference limit are consistent with ACS. If the ECG finding is normal and results of two troponin tests are negative, risk stratification should be calculated using Thrombosis in Myocardial Infarction (TIMI) or HEART (History, ECG, Age, Risk factors, initial Troponin) score. Based on the score, further evaluation to exclude coronary artery disease (CAD) is completed during hospitalization or after discharge, using exercise treadmill testing, stress echocardiography, myocardial perfusion scintigraphy, or coronary computed tomography angiography. Although ACS is less likely in outpatients, CAD must still be considered. Many patients with ACS are misdiagnosed. Between 2% and 5% of patients are inappropriately discharged from the ED. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Year:  2020        PMID: 32150364

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  5 in total

1.  Diagnostic efficacy of serum ST2 in patients with ASC.

Authors:  Yaping Ren; Min Hou; Yunxia Ren; Lei Zhang
Journal:  J Clin Lab Anal       Date:  2022-05-25       Impact factor: 3.124

2.  Serum Metabonomic Study of Patients With Acute Coronary Syndrome Using Ultra-Performance Liquid Chromatography Orbitrap Mass Spectrometer.

Authors:  Lei Song; Zhongxiao Zhang; Zhaohui Qiu; Tingbo Jiang
Journal:  Front Cardiovasc Med       Date:  2021-02-26

3.  microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome.

Authors:  Jinming Yu; Yongmei Li; Deguo Leng; Cheng Cao; Yongzhi Yu; Yijuan Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Evolocumab enables rapid LDL-C reduction and inflammatory modulation during in-hospital stage of acute coronary syndrome: A pilot study on Chinese patients.

Authors:  Ziwei Ou; Zaixin Yu; Benhui Liang; Lin Zhao; Jianghua Li; Xinli Pang; Qiyun Liu; Cong Xu; Shaohong Dong; Xin Sun; Tangzhiming Li
Journal:  Front Cardiovasc Med       Date:  2022-08-09

5.  P2X7R-NEK7-NLRP3 Inflammasome Activation: A Novel Therapeutic Pathway of Qishen Granule in the Treatment of Acute Myocardial Ischemia.

Authors:  Yanqin Li; Xiaoqian Sun; Xiangning Liu; Junjun Li; Xuan Li; Gang Wang; Yizhou Liu; Xiangyu Lu; Lingwen Cui; Mingyan Shao; Yong Wang; Wei Wang; Chun Li
Journal:  J Inflamm Res       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.